IgG / Thermo Fisher / LG / Zyngenia Inc. / Taconic Farms Inc. / Blue Door Pharma / Grinnell / Thermo Electron / MRD / GE Healthcare / BD Biosciences / Harlan Laboratories / Im SA / PerkinElmer / IDT Technologies / KPL Inc. / /
Country
United States / / /
Event
M&A / /
Facility
Skaggs Institute / scaffold MRD / Scripps Research Institute / /
IndustryTerm
serum-free media / chemical approach / multi-valent technology / antigen binding site / animal protocols / adalimumab heavy chain / light chain / treatment of human disease / sensor chip / /
MedicalCondition
arthritis / chronic lymphocytic leukemia / ErbB2- and angiogenesis-dependent xenograft tumor / human tumor / early breast cancer / J Cancer / pancreatic adenocarcinoma cell line / metastatic breast cancer / xenograft tumor / human diseases / metastatic breast cancers / few human diseases / tumor / Cancer / Female NOD/SCID / angiogenesis-dependent xenograft tumor / tumors / disease / also mediate solid tumor / diseases / human disease / /
MedicalTreatment
oncology therapies / /
Organization
2The Skaggs Institute for Chemical Biology and the Departments of Molecular Biology and Chemistry / Institutional Animal Care and Use Committee / Scripps Research Institute / /
Person
David W. LaFleur / Carlos F. Barbas / Elvin Ng / Anton Nguyen / Ella Biotec / Carlos F. Barbas / III / /
Brief Report mAbs 5:2, 208–218; March/April 2013; © 2013 Landes Bioscience Monoclonal antibody therapeutics with up to five specificities